ViiV Healthcare, today announced the positive findings of a pooled analysis of COVID-19-related impacts across the investigational long-acting cabotegravir and rilpivirine clinical ... Oct 21
Both candidate vaccines contain a recombinant subunit pre-fusion RSV antigen which is believed to trigger the required immune response... Oct 21
-Advertisements-